Mechanism of Action and Pharmacological Effects
The drug acts as a source of potassium ions ($K^+$), which are critical for normal myocardial electrophysiology. Kalii chloridum is most effective when administered as part of polarizing solutions.
An important pharmacological nuance: full cellular uptake of potassium by cardiomyocytes requires magnesium. $Mg^{2+}$ ions act as activators of the $Na^+,K^+$-ATPase enzyme. This specific enzyme provides active transport of potassium ions from the extracellular space into cardiac muscle cells. Without adequate pump function, correction of intracellular potassium deficiency is ineffective.
Indications for Use
The drug is prescribed strictly for confirmed electrolyte imbalances. Key indications include:
- Tachyarrhythmias and extrasystoles. A key condition for use: rhythm disturbances must be specifically driven by hypokalemia or hypomagnesemia (reduced blood concentrations of these ions).
- Cardiac glycoside toxicity. Digitalis toxicity causes a marked potassium deficit. Administration of Kalii chloridum is a critical step in restoring electrolyte balance (along with digoxin antibodies, atropine for AV block, and unithiol to restore $Na^+,K^+$-ATPase activity).
- Correction of diuretic-induced hypokalemia. Saluretics (diuretics) actively deplete body potassium. Combining saluretics with potassium chloride is a classic example of rational drug combination, making therapy appropriate by neutralizing the adverse effects of the baseline drug.
Role in Combination Drugs
In clinical practice, Kalii chloridum is often a component of fixed-dose antihypertensive agents. This ensures synergistic action and patient convenience.
Classic examples include reserpine-based sympatholytic lines:
- Adelphane-Esidrex-K: a quadruple combination including reserpine, the direct vasodilator dihydralazine, the diuretic hydrochlorothiazide, and potassium chloride (0.6 g). Potassium is added here specifically to prevent thiazide diuretic-induced hypokalemia.
- Triresed K: an analogue with complex antihypertensive action and obligatory potassium correction (containing reserpine, dihydralazine sulfate, hydrochlorothiazide, and potassium chloride).
Potassium is also used in non-fixed combinations with magnesium (e.g., potassium and magnesium aspartate — Panangin, Asparcam).
Adverse Effects
Potassium therapy requires strict dosage monitoring due to the risk of hyperkalemia and specific adverse reactions:
- Cardiac: depression of myocardial conduction, development of atrioventricular block (AV block).
- Neurological: paresthesias (numbness, tingling sensations).
- Gastrointestinal: dyspepsia (especially with oral administration).
Administration Guidelines
The drug is administered orally (per os) or intravenously.
For intravenous use, a 4% solution in 10 and 20 mL ampoules is utilized. Warning: this is a concentrate for preparing infusion solutions!
Dilution rule: for intravenous infusion, dissolve 2–2.5 g of Kalii chloridum in 500 mL of 5% glucose solution.
Prescription example for the concentrate: ```latin Rp.: Sol. Kalii chloridi 4% — 20 ml D.t.d. N. 10 in ampull. S. Intravenous drip. Contents of 3 ampoules (2.4 g KCl) dissolved in 500 ml of 5% glucose solution. ```